Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-26,913
Closed -$7M 1738
2025
Q3
$7M Buy
26,913
+20,684
+332% +$5.44M 0.17% 123
2025
Q2
$1.52M Buy
+6,229
New +$1.55M 0.04% 732
2024
Q4
Sell
-5,741
Closed -$1.82M 1398
2024
Q3
$1.82M Buy
5,741
+3,696
+181% +$1.32M 0.11% 236
2024
Q2
$764K Sell
2,045
-3,629
-64% -$1.23M 0.04% 618
2024
Q1
$1.97M Buy
5,674
+534
+10% +$202K 0.15% 171
2023
Q4
$2.35M Buy
+5,140
New +$2.53M 0.22% 107
2023
Q3
Sell
-3,658
Closed -$1.64M 1280
2023
Q2
$1.64M Buy
3,658
+1,936
+112% +$975K 0.17% 145
2023
Q1
$836K Buy
+1,722
New +$851K 0.1% 306
2022
Q3
Sell
-3,074
Closed -$1.44M 1103
2022
Q2
$1.44M Buy
+3,074
New +$1.37M 0.19% 148
2022
Q1
Sell
-2,596
Closed -$1.2M 820
2021
Q4
$1.2M Sell
2,596
-676
-21% -$299K 0.29% 88
2021
Q3
$1.27M Buy
+3,272
New +$1.39M 0.23% 135
2021
Q2
Sell
-3,069
Closed -$1.31M 741
2021
Q1
$1.31M Buy
+3,069
New +$1.23M 0.35% 56

Other funds holding HUM

Y-Intercept (HK)'s HUM Position: Q4 2025 in Review

Y-Intercept (HK) sold out of Humana (HUM) in Q4 2025, closing a stake of 26,913 shares — an estimated $7M sold.

Y-Intercept (HK) first reported a position in HUM in Q1 2021 and held it in 12 quarters. The position peaked at $7M in Q3 2025. 862 funds tracked by Wall St. Rank hold HUM as of Q4 2025.

  • Y-Intercept (HK) reported no remaining Humana position as of Q4 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 26,913 Humana shares in Q4 2025, an estimated $7M.
  • Y-Intercept (HK) first reported a position in Humana in Q1 2021 and held it in 12 quarters.
  • Y-Intercept (HK)'s Humana position peaked at $7M in Q3 2025.
  • 862 funds tracked by Wall St. Rank held Humana as of Q4 2025.

Based on Y-Intercept (HK)'s 13F filing for Q4 2025, filed 13 Feb 2026.